ATE250064T1 - Beta, beta'-dihydroxy meso-substituierte chlorine,isobacteriochlorine und bacteriochlorine und verfahren zu ihrer herstellung aus beta, beta'- unsubstutuierten tetrapyrolischen macrocyclen - Google Patents

Beta, beta'-dihydroxy meso-substituierte chlorine,isobacteriochlorine und bacteriochlorine und verfahren zu ihrer herstellung aus beta, beta'- unsubstutuierten tetrapyrolischen macrocyclen

Info

Publication number
ATE250064T1
ATE250064T1 AT95944791T AT95944791T ATE250064T1 AT E250064 T1 ATE250064 T1 AT E250064T1 AT 95944791 T AT95944791 T AT 95944791T AT 95944791 T AT95944791 T AT 95944791T AT E250064 T1 ATE250064 T1 AT E250064T1
Authority
AT
Austria
Prior art keywords
beta
isobacteriochlorines
tetrapyrolic
unsubstuted
bacteriochlorines
Prior art date
Application number
AT95944791T
Other languages
English (en)
Inventor
David Dolphin
Christian Department Bruckner
Berkeley California
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia filed Critical Univ British Columbia
Application granted granted Critical
Publication of ATE250064T1 publication Critical patent/ATE250064T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0485—Porphyrins, texaphyrins wherein the nitrogen atoms forming the central ring system complex the radioactive metal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Radiology & Medical Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT95944791T 1994-10-26 1995-10-25 Beta, beta'-dihydroxy meso-substituierte chlorine,isobacteriochlorine und bacteriochlorine und verfahren zu ihrer herstellung aus beta, beta'- unsubstutuierten tetrapyrolischen macrocyclen ATE250064T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/329,577 US5648485A (en) 1994-10-26 1994-10-26 β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
PCT/CA1995/000602 WO1996013504A1 (en) 1994-10-26 1995-10-25 β,β'-DIHYDROXY MESO-SUBSTITUTED CHLORINS, ISOBACTERIOCHLORINS, BACTERIOCHLORINS, AND METHODS FOR MAKING THE SAME FROM β,β'-UNSUBSTITUTED TETRAPYRROLIC MACROCYCLES

Publications (1)

Publication Number Publication Date
ATE250064T1 true ATE250064T1 (de) 2003-10-15

Family

ID=23286058

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95944791T ATE250064T1 (de) 1994-10-26 1995-10-25 Beta, beta'-dihydroxy meso-substituierte chlorine,isobacteriochlorine und bacteriochlorine und verfahren zu ihrer herstellung aus beta, beta'- unsubstutuierten tetrapyrolischen macrocyclen

Country Status (20)

Country Link
US (2) US5648485A (de)
EP (1) EP0804439B1 (de)
JP (2) JP3228296B2 (de)
KR (1) KR970707129A (de)
CN (1) CN1043143C (de)
AT (1) ATE250064T1 (de)
AU (1) AU704971B2 (de)
CA (1) CA2199399C (de)
CZ (1) CZ294496B6 (de)
DE (1) DE69531795T2 (de)
DK (1) DK0804439T3 (de)
ES (1) ES2208701T3 (de)
FI (1) FI971734L (de)
HU (1) HU221102B1 (de)
NO (1) NO308411B1 (de)
NZ (1) NZ294203A (de)
PL (1) PL182239B1 (de)
PT (1) PT804439E (de)
TW (1) TW301648B (de)
WO (1) WO1996013504A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648485A (en) * 1994-10-26 1997-07-15 University Of British Columbia β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
GB9610967D0 (en) 1996-05-24 1996-07-31 Cambridge Antibody Tech Specific binding members,materials and methods
CA2278245A1 (en) * 1997-01-21 1998-07-23 The American National Red Cross Intracellular and extracellular decontamination of whole blood and blood components by amphiphilic phenothiazin-5-ium dyes plus light
US6444194B1 (en) 1997-02-14 2002-09-03 Miravant Pharmaceuticals, Inc. Indium photosensitizers for PDT
FR2760841B1 (fr) * 1997-03-12 1999-04-16 Commissariat Energie Atomique Determination par resonance magnetique nucleaire de la configuration absolue d'amino-acides ou de leur derives et complexes metalliques de porphyrines chirales utilisables pour cette determination
DE19814405C2 (de) 1998-03-31 2000-03-02 Schastak Astrid Porphyrine und ihre Verwendung als Photosensitizer
US20030176663A1 (en) * 1998-05-11 2003-09-18 Eidgenossische Technische Hochscule Specific binding molecules for scintigraphy
EP1123369B1 (de) 1998-10-20 2006-03-01 The Procter & Gamble Company Waschmittel enthaltend modifizierte alkylbenzolsulfonate
HUP0104608A3 (en) 1998-10-20 2002-11-28 Procter & Gamble Tenzide mixture comprising modified alkylbenzene sulfonates and laundry detergents containing thereof, and process for preparation of the mixture and for use of the detergents
US7022843B1 (en) 1999-04-14 2006-04-04 The University Of British Columbia β,β′-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
WO2000061584A1 (en) * 1999-04-14 2000-10-19 The University Of British Columbia IMPROVED β,β,-DIHYDROXY MESO-SUBSTITUTED CHLORINS, ISOBACTERIOCHLORINS, AND BACTERIOCHLORINS
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
US6376483B1 (en) 1999-05-27 2002-04-23 Miravant Pharmaceuticals, Inc. Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production
US7166719B2 (en) 2002-06-27 2007-01-23 Health Research, Inc. Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy
US7897140B2 (en) * 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
CA2400622A1 (en) 2000-02-24 2001-08-30 Eidgenossische Technische Hochschule Zurich Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis
US6693093B2 (en) * 2000-05-08 2004-02-17 The University Of British Columbia (Ubc) Drug delivery systems for photodynamic therapy
US7282215B2 (en) 2000-05-08 2007-10-16 The University Of British Columbia Supports for photosensitizer formulations
US6559374B2 (en) * 2000-07-21 2003-05-06 North Carolina State University Trans beta substituted chlorins and methods of making and using the same
EP1381629B1 (de) * 2000-09-07 2008-09-10 Bayer Schering Pharma Aktiengesellschaft REZEPTOR DER EDb-FIBRONEKTIN-DOMÄNE (II)
ATE302209T1 (de) 2000-09-08 2005-09-15 San Ei Gen Ffi Inc Tetraphenylbacteriochlorin-derivate und diese enthaltenden zusammensetzungen
BR0214009A (pt) * 2001-11-09 2004-11-03 Quadra Logic Tech Inc Método e composição para estimular o crescimento de pelos sobre a pele
US7053210B2 (en) * 2002-07-02 2006-05-30 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
WO2004063200A1 (en) * 2003-01-16 2004-07-29 Techno Mart Co., Ltd Porphyrin derivatives
US7057100B2 (en) * 2003-06-26 2006-06-06 The J.C. Robinson Seed Co. Inbred corn line W23129
GB0323358D0 (en) * 2003-10-06 2003-11-05 Green Grass Design Ltd Novel compounds and processes
JP4635493B2 (ja) * 2003-10-09 2011-02-23 日本製紙株式会社 ダル調塗工紙
GB2408265A (en) * 2003-11-21 2005-05-25 Univ Sheffield Water-soluble hyperbranched polymer porphyrins
US6995260B2 (en) * 2004-05-20 2006-02-07 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
WO2006089122A2 (en) 2005-02-18 2006-08-24 North Carolina State University De novo synthesis of bacteriochlorins
WO2007064841A2 (en) * 2005-11-30 2007-06-07 North Carolina State University Porphyrinic compounds for use in flow cytometry
WO2009038659A2 (en) * 2007-09-14 2009-03-26 Health Research, Inc. Organically modified silica nanoparticles with covalently incorporated photosensitizers for drug delivery in photodynamic therapy
US8253725B2 (en) * 2007-12-28 2012-08-28 St. Jude Medical, Atrial Fibrillation Division, Inc. Method and system for generating surface models of geometric structures
US20120034156A1 (en) * 2010-08-03 2012-02-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Artificial cells
RU2574062C9 (ru) * 2008-09-18 2016-10-27 Биолитек Унтернеменсбетайлигунгс Ii Аг НОВЫЙ СПОСОБ И ПРИМЕНЕНИЕ НЕСИММЕТРИЧНО мезо-ЗАМЕЩЕННЫХ ПОРФИРИНОВ И ХЛОРИНОВ ДЛЯ ФДТ
GB0819594D0 (en) 2008-10-24 2008-12-03 Univ Coimbrra Process
CN102325550B (zh) 2008-12-16 2016-10-26 Qlt公司 光动力学疗法和抗vegf剂在治疗有害的脉络膜新血管系统中的联合应用
US9211283B2 (en) 2009-12-11 2015-12-15 Biolitec Pharma Marketing Ltd Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
EP2531206B1 (de) 2010-02-04 2017-05-31 Morphotek, Inc. Chlorotoxinpolypeptide sowie konjugate und verwendungen davon
WO2012012809A2 (en) * 2010-07-22 2012-01-26 Ceramoptec Gmbh APPLICATION OF β-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT
WO2013003507A1 (en) 2011-06-27 2013-01-03 Morphotek, Inc. Multifunctional agents
CA2853705C (en) 2011-10-25 2021-10-12 Memorial Sloan-Kettering Cancer Center Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer
AU2013334102B2 (en) 2012-10-26 2018-08-16 Memorial Sloan-Kettering Cancer Center Modulators of resistant androgen receptor
BR112015023568B8 (pt) 2013-03-15 2024-01-02 Ann Mcfarland Sherri Composto à base de metal como composto fotodinâmico
EP3087182B1 (de) 2013-12-23 2019-03-20 Memorial Sloan-Kettering Cancer Center Verfahren und zusammensetzungen zur behandlung von krebs unter verwendung von peptidnukleinsäurebasiertem wirkstoff
TWI474536B (zh) 2014-07-01 2015-02-21 Nat Univ Chung Hsing 紫質光敏染料化合物以及染料敏化太陽能電池
WO2016051361A1 (en) 2014-09-30 2016-04-07 Biolitec Unternehmensbeteiligungs Ii Ag Specifically meso-substituted porphyrins and chlorins for photodynamic therapy
RU2615770C1 (ru) * 2015-12-21 2017-04-11 Общество с ограниченной ответственностью "Пермская химическая компания" Борированные производные фторированных бактериохлоринов и их металлокомплексов, обладающие противоопухолевой активностью
CN110730782B (zh) * 2016-12-05 2024-01-02 光盐生物科技有限公司 光动力治疗化合物和光动力治疗方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648485A (en) * 1994-10-26 1997-07-15 University Of British Columbia β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
US6376483B1 (en) * 1999-05-27 2002-04-23 Miravant Pharmaceuticals, Inc. Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production

Also Published As

Publication number Publication date
HUT77008A (hu) 1998-03-02
NO971952D0 (no) 1997-04-25
MX9703013A (es) 1997-07-31
DK0804439T3 (da) 2004-02-02
PL182239B1 (pl) 2001-11-30
NO308411B1 (no) 2000-09-11
EP0804439B1 (de) 2003-09-17
JPH10507766A (ja) 1998-07-28
CN1161697A (zh) 1997-10-08
CZ294496B6 (cs) 2005-01-12
EP0804439A1 (de) 1997-11-05
CN1043143C (zh) 1999-04-28
JP3228296B2 (ja) 2001-11-12
KR970707129A (ko) 1997-12-01
FI971734A0 (fi) 1997-04-23
US5831088A (en) 1998-11-03
AU704971B2 (en) 1999-05-13
NO971952L (no) 1997-04-25
HU221102B1 (en) 2002-08-28
CZ115597A3 (en) 1997-09-17
CA2199399C (en) 2004-02-24
JP2001294589A (ja) 2001-10-23
NZ294203A (en) 1998-12-23
US5648485A (en) 1997-07-15
FI971734A7 (fi) 1997-04-23
FI971734L (fi) 1997-04-23
PT804439E (pt) 2004-02-27
DE69531795D1 (de) 2003-10-23
ES2208701T3 (es) 2004-06-16
TW301648B (de) 1997-04-01
CA2199399A1 (en) 1996-05-09
DE69531795T2 (de) 2004-08-05
AU3695195A (en) 1996-05-23
PL319907A1 (en) 1997-09-01
WO1996013504A1 (en) 1996-05-09

Similar Documents

Publication Publication Date Title
ATE250064T1 (de) Beta, beta'-dihydroxy meso-substituierte chlorine,isobacteriochlorine und bacteriochlorine und verfahren zu ihrer herstellung aus beta, beta'- unsubstutuierten tetrapyrolischen macrocyclen
IL105421A0 (en) Taxol derivatives
PL327169A1 (en) Naphtyl-substituted derivatives of benzimidazole as anticoagulants
AU5993896A (en) Semicarbazones having cns activity and pharmaceutical preparations containing same
DE69113155D1 (de) 17-beta-substituierte-4-aza-5-alpha-androstan-3-one-derivate und verfahren zu ihrer herstellung.
EP0482410A3 (en) Anti-microbial compounds, including substituted 2-cyclohexyl-amine derivatives and their preparation
DE69221563D1 (de) Polyfluoralkylthiopoly(ethylimidazolium)-Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als biozide Mittel
ATE220681T1 (de) Wasserlösliche camptothecin-derivate, verfahren zu deren herstellung und deren verwendung als antitumor-mittel
NO980648L (no) Fremgangsmåte for diagnostisk bildeanalyse ved anvendelse av metallkomplekser av nitrogeninneholdende makrocykliske ligander
IT1271325B (it) Composti diastereomericamente puri derivati da 3-oxo e 3-tioxo-4-azaandrostani e loro uso come antiandrogeni
NO980647L (no) Fremgangsmåte for diagnostisk bildeanalyse ved anvendelse av biokonjugater av metallkomplekser av nitrogeninneholdende makrocykliske ligander
PL309402A1 (en) Novel steroides
CA2185443A1 (en) Method for the separation and purification of fullerenes
DE69403541D1 (de) Lacton-Verbindung und Verfahren zu ihrer Herstellung
EP0900785A3 (de) Mit Vitamin A verwandte Verbindungen und Verfahren zu ihrer Herstellung
DE59206545D1 (de) Modifizierte Huminate, Verfahren zu ihrer Herstellung und Verwendung
DE59109029D1 (de) 3-substituierte Cephalosporine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ATE18560T1 (de) Cephemderivate und verfahren zu ihrer herstellung.
NZ240882A (en) 3-(2-chloro-4-trifluoromethylphenoxy)-1-azetidine carboxamide derivatives, pharmaceutical compositions, and intermediate compounds therefor
ATE17246T1 (de) Substituierte dibenzodiazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE152710T1 (de) (thia)cycloalkyl(b)indole, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen
CA2207443A1 (en) Tricyclic compounds
ZA912535B (en) Substituted 3-thia-and 3-oxa-alkylflavones,a process for their preparation,the use thereof,medicaments based on these compounds and intermediates
YU49004B (sh) LANOSTA-7,9-DIEN-3Гџ, 32-DIOL I POSTUPAK ZA NJEGOVO DOBIJANJE

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0804439

Country of ref document: EP

REN Ceased due to non-payment of the annual fee